OTCM
AFGVF
Market cap71mUSD
Feb 11, Last price
0.57USD
Name
AGFA Gevaert NV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems worldwide. It operates through four segments: HealthCare IT, Digital Print and Chemicals, Radiology Solutions, and Contractor Operations and Services (CONOPS). The Healthcare IT segment provides healthcare's enterprise imaging platform. The Digital Print & Chemicals segment offers printers, inks, and software for sign and display and packaging printing companies; inkjet inks and fluids for various industrial inkjet applications, such as signs, displays, billboards, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry; and printable synthetic papers and films for graphics, non-destructive testing, aerial photography, and printed circuit board production. The Radiology Solutions segment provides analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. This segment also offers SmartXR that provides radiographers with predictive workflow assistance which includes digital radiography tools for dose, alignment, patient positioning, image rotation, and others. The CONOPS segment engages in supply of film and chemicals, as well support services. It sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
Related entities
Subsidiaries (5)
AGFA
AGFA FINANCE
AGFA FINCO
AGFA HEALTHCARE
AGFA HEALTHCARE INDIA PRIVATE LIMITED
Key people
Frank Aranzana
Non-Executive Independent Chairman of the Board · since 2020
Fiona Lam
Chief Financial Officer, Member of the Executive Committee · since 2024
Gunther Koch
Chief Human Resources Officer and Head of Sustainability, Member of the Executive Board · since 2023
Pascal Juery
Chief Executive Officer, Executive Director, Member of the Executive Committee · since 2020
Nathalie Mccaughley
President of the HealthCare IT Division, Member of the Executive Committee · since 2022
Jeroen Spruyt
President - Radiology Solutions, Member of the Executive Committee · since 2024
Vincent Wille
President - Digital Print & Chemicals, Member of the Executive Committee · since 2021
Non-Executive Director · since 2025
Non-Executive Director · since 2021
Line De Decker
Non-Executive Independent Director · since 2022
Michel Govaert
Non-Executive Independent Director · since 2025
Non-Executive Independent Director · since 2018
Helen Routh
Non-Executive Independent Director · since 2019
Headquarters & legal address
SEPTESTRAAT 27
MORTSEL, VAN 2640
BE
MORTSEL, VAN 2640
BE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||